Biomea Fusion, Inc. (BMEA) Financials

BMEA Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 225.1 million 25.5 million
2023-06-30 248.7 million 24.4 million
2023-03-31 112.6 million 29.5 million
2022-12-31 129.3 million 20.8 million

BMEA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -23.9 million 3.6 million
2023-06-30 -26.2 million 3.4 million
2023-03-31 -27.0 million 3.2 million
2022-12-31 -20.9 million 2.7 million

BMEA Net Income

No data available :(

BMEA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 199.5 million - 12.1 million
2023-06-30 223.3 million - 12.7 million
2023-03-31 86.7 million - 13.3 million
2022-12-31 113.4 million - 2.3 million

BMEA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 35.7 million
2023-06-30 35.3 million
2023-03-31 29.6 million
2022-12-31 29.4 million

BMEA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 39000 25.3 million 5.8 million -
2023-06-30 417000 21.9 million 5.7 million -
2023-03-31 2.9 million 24.4 million 5.6 million -
2022-12-31 712000 20.5 million 5.7 million -

BMEA Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 1.1 million
2023-06-30 - 1.1 million
2023-03-31 - 905000
2022-12-31 - 326000

BMEA

Price: $12.35

52 week price:
8.13
43.69

Earnings Per Share: -3.44 USD

P/E Ratio: -6.17

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 55800

Market Capitalization: 465.8 million

Links: